{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:42:46Z","timestamp":1789587766609,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40744-026-00844-3","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:33:42Z","timestamp":1774535622000},"page":"719-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescription Patterns in Psoriatic Arthritis: Insights from a Sex-Based Perspective"],"prefix":"10.1007","volume":"13","author":[{"given":"Mauro","family":"Fatica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"844_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17:65\u201370.","journal-title":"Clin Med (Lond)"},{"key":"844_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3899\/jrheum.190054","volume":"46","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol. 2019;46:1428\u201330.","journal-title":"J Rheumatol"},{"key":"844_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1080\/14712598.2022.2152321","volume":"22","author":"F Sunzini","year":"2022","unstructured":"Sunzini F, D\u2019Antonio A, Fatica M, et al. What\u2019s new and what\u2019s next for biological and targeted synthetic treatments in psoriatic arthritis? Expert Opin Biol Ther. 2022;22:1545\u201359.","journal-title":"Expert Opin Biol Ther"},{"key":"844_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.220386","volume":"50","author":"LC Coates","year":"2023","unstructured":"Coates LC, van der Horst-Bruinsma IE, Lubrano E, et al. Sex-specific differences in patients with psoriatic arthritis: a systematic review. J Rheumatol. 2023;50:488\u201396.","journal-title":"J Rheumatol"},{"key":"844_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40744-023-00535-3","volume":"10","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, Fatica M, et al. Psoriatic arthritis in males and females: differences and similarities. Rheumatol Ther. 2023;10:589\u201399.","journal-title":"Rheumatol Ther"},{"key":"844_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3899\/jrheum.220154","volume":"50","author":"L Gossec","year":"2023","unstructured":"Gossec L, Walsh JA, Michaud K, et al. Women with psoriatic arthritis experience higher disease burden than men: findings from a real-world survey in the United States and Europe. J Rheumatol. 2023;50:192\u20136.","journal-title":"J Rheumatol"},{"key":"844_CR7","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s10067-017-3769-4","volume":"36","author":"MS Chimenti","year":"2017","unstructured":"Chimenti MS, Triggianese P, Conigliaro P, et al. A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors. Clin Rheumatol. 2017;36:2253\u201360.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"844_CR8","doi-asserted-by":"publisher","first-page":"e716","DOI":"10.1016\/S2665-9913(23)00264-3","volume":"5","author":"L Eder","year":"2023","unstructured":"Eder L, Mylvaganam S, Pardo Pardo J, et al. Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis. Lancet Rheumatol. 2023;5(12):e716\u201327.","journal-title":"Lancet Rheumatol"},{"key":"844_CR9","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, et al. CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"844_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59:686\u201391.","journal-title":"Arthritis Rheum"},{"key":"844_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2133.1999.02963.x","volume":"141","author":"DM Ashcroft","year":"1999","unstructured":"Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol. 1999;141:185\u201391.","journal-title":"Br J Dermatol"},{"key":"844_CR12","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3899\/jrheum.150595","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Parsons WJ, et al. Patient\u2019s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol. 2015;42:2332\u20138.","journal-title":"J Rheumatol"},{"key":"844_CR13","doi-asserted-by":"publisher","first-page":"e001170","DOI":"10.1136\/rmdopen-2020-001170","volume":"6","author":"E Lubrano","year":"2020","unstructured":"Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Ca\u00f1ete JD, Perrotta FM. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. RMD Open. 2020;6:e001170.","journal-title":"RMD Open"},{"key":"844_CR14","first-page":"123","volume":"11","author":"R Ranza","year":"1993","unstructured":"Ranza R, Marchesoni A, Calori G, et al. The Italian version of the functional disability index of the health assessment questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol. 1993;11:123\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"844_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012\u20139.","journal-title":"Ann Rheum Dis"},{"key":"844_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, et al. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811\u20138.","journal-title":"Ann Rheum Dis"},{"key":"844_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwel PS. Defining disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69:48\u201353.","journal-title":"Ann Rheum Dis"},{"key":"844_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319\u201329.","journal-title":"Semin Arthritis Rheum"},{"key":"844_CR19","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1038\/s41598-021-90442-w","volume":"11","author":"A Prior-Espa\u00f1ol","year":"2021","unstructured":"Prior-Espa\u00f1ol A, S\u00e1nchez-Piedra C, Campos J, et al. Clinical factors associated with discontinuation of ts\/bDMARDs in rheumatic patients from the BIOBADASER III registry. Sci Rep. 2021;11:11091.","journal-title":"Sci Rep"},{"key":"844_CR20","first-page":"205","volume":"52","author":"E Ortona","year":"2016","unstructured":"Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita. 2016;52:205\u201312.","journal-title":"Ann Ist Super Sanita"},{"key":"844_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226150","author":"P Karmacharya","year":"2024","unstructured":"Karmacharya P, Crofford LJ, Byrne DW, et al. Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium. Ann Rheum Dis. 2024. https:\/\/doi.org\/10.1136\/ard-2024-226150.","journal-title":"Ann Rheum Dis"},{"key":"844_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/ph15030298","volume":"15","author":"AC Brabete","year":"2022","unstructured":"Brabete AC, Greaves L, Maximos M, Huber E, Li A, L\u00ea ML. A sex- and gender-based analysis of adverse drug reactions: a scoping review of pharmacovigilance databases. Pharmaceuticals (Basel). 2022;15:298.","journal-title":"Pharmaceuticals (Basel)"},{"key":"844_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/metabo10030107","volume":"10","author":"E Toussirot","year":"2020","unstructured":"Toussirot E. The interrelations between biological and targeted synthetic agents used in inflammatory joint diseases, and obesity or body composition. Metabolites. 2020;10:107.","journal-title":"Metabolites"},{"key":"844_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/14712598.2024.2384090","volume":"24","author":"F Caso","year":"2024","unstructured":"Caso F, Fatica M, Ferraioli M, et al. The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in psoriatic arthritis. Expert Opin Biol Ther. 2024;24:719\u201331.","journal-title":"Expert Opin Biol Ther"},{"key":"844_CR25","doi-asserted-by":"publisher","first-page":"101423","DOI":"10.1016\/j.berh.2019.06.005","volume":"33","author":"SS Zhao","year":"2019","unstructured":"Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33:101423.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"844_CR26","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1016\/S2665-9913(23)00274-6","volume":"5","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Massimo Perrotta F. Sex-related differences in psoriatic arthritis. Lancet Rheumatol. 2023;5:e699\u2013701.","journal-title":"Lancet Rheumatol"},{"key":"844_CR27","doi-asserted-by":"publisher","first-page":"e001681","DOI":"10.1136\/rmdopen-2021-001681","volume":"7","author":"MS Chimenti","year":"2021","unstructured":"Chimenti MS, Alten R, D\u2019Agostino MA, et al. Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients. RMD Open. 2021;7:e001681.","journal-title":"RMD Open"},{"key":"844_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40744-023-00574-w","volume":"10","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Difficult to treat and refractory to treatment in psoriatic arthritis. Rheumatol Ther. 2023;10:1119\u201325.","journal-title":"Rheumatol Ther"},{"key":"844_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41584-025-01329-3","volume":"22","author":"F Proft","year":"2026","unstructured":"Proft F, Ribeiro AL, Singla S, et al. Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative. Nat Rev Rheumatol. 2026;22:132\u201344.","journal-title":"Nat Rev Rheumatol"},{"key":"844_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","volume":"85","author":"H Marzo-Ortega","year":"2026","unstructured":"Marzo-Ortega H, Harrison SR, Fragoulis GE, et al. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis. Ann Rheum Dis. 2026;85:61\u201374.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00844-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00844-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00844-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:46:28Z","timestamp":1779525988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00844-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00844-3","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ennio Lubrano and Fabio Massimo Perrotta are members of the Editorial Board of Rheumatology and Therapy. Ennio Lubrano and Fabio Massimo Perrotta were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Mauro Fatica, Paola Conigliaro, and Maria Sole Chimenti declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Institutional Review Board of the University of Molise (protocol no. 0001-017-2021), which provided the approval for both centers (the University of Molise and the University of Tor Vergata) and was performed according to the Helsinki Declaration. Written informed consent to use the clinical data of all participants was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}